FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME

FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME

The present invention relates to a method for assessing whether a subject has Polycystic Ovarian Syndrome (PCOS) or is at risk of developing PCOS, to a method of selecting a patient for therapy of PCOS, to a method for monitoring PCOS progression or for monitoring response to treatment and to a comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SILLMAN, Johanna Carolina, MANG, Anika, HUND, Martin, MARTIN, Klammer, ALLEGRANZA, Deirdre Mary, DI DOMENICO, Annunziata
Format: Patent
Sprache:eng ; fre
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SILLMAN, Johanna Carolina
MANG, Anika
HUND, Martin
MARTIN, Klammer
ALLEGRANZA, Deirdre Mary
DI DOMENICO, Annunziata
description The present invention relates to a method for assessing whether a subject has Polycystic Ovarian Syndrome (PCOS) or is at risk of developing PCOS, to a method of selecting a patient for therapy of PCOS, to a method for monitoring PCOS progression or for monitoring response to treatment and to a computer- implemented method for assessing a subject with suspected PCOS, by determining the amount or concentration of Fibroblast Growth Factor-Binding Protein 1 (FGFBP1) in a sample of the subject. La présente invention concerne un procédé pour évaluer si un sujet a un syndrome des ovaires polykystiques (SOPK) ou est à risque de développer un SOPK, un procédé de sélection d'un patient pour une thérapie de SOPK, un procédé de surveillance de la progression du SOPK ou de surveillance de la réponse à un traitement et un procédé mis en oeuvre par ordinateur pour évaluer un sujet suspecté d'être atteint de SOPK, par détermination de la quantité ou de la concentration de la protéine 1 de liaison au facteur de croissance des fibroblastes (FGFBP1) dans un échantillon du sujet.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024017985A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024017985A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024017985A13</originalsourceid><addsrcrecordid>eNqNy7sKwjAUgOEuDqK-wwGXdhAaL6hj7g22OSUJlk6lSJxEC3Xx7e3gAzj9y_fPk48yzCErqQ-gHTahAEV5QAfMWGGshtphkMYCgVRpxWqSAfWQshJRZJPCirqLdKCmJxQShKHaojceUEGNZctbHwwHvFJnqAXfWuGwkstkdu8fY1z9ukjWSgZebOLw6uI49Lf4jO-uwW2-3efkeD4dKNn9p75HIzqV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME</title><source>esp@cenet</source><creator>SILLMAN, Johanna Carolina ; MANG, Anika ; HUND, Martin ; MARTIN, Klammer ; ALLEGRANZA, Deirdre Mary ; DI DOMENICO, Annunziata</creator><creatorcontrib>SILLMAN, Johanna Carolina ; MANG, Anika ; HUND, Martin ; MARTIN, Klammer ; ALLEGRANZA, Deirdre Mary ; DI DOMENICO, Annunziata</creatorcontrib><description>The present invention relates to a method for assessing whether a subject has Polycystic Ovarian Syndrome (PCOS) or is at risk of developing PCOS, to a method of selecting a patient for therapy of PCOS, to a method for monitoring PCOS progression or for monitoring response to treatment and to a computer- implemented method for assessing a subject with suspected PCOS, by determining the amount or concentration of Fibroblast Growth Factor-Binding Protein 1 (FGFBP1) in a sample of the subject. La présente invention concerne un procédé pour évaluer si un sujet a un syndrome des ovaires polykystiques (SOPK) ou est à risque de développer un SOPK, un procédé de sélection d'un patient pour une thérapie de SOPK, un procédé de surveillance de la progression du SOPK ou de surveillance de la réponse à un traitement et un procédé mis en oeuvre par ordinateur pour évaluer un sujet suspecté d'être atteint de SOPK, par détermination de la quantité ou de la concentration de la protéine 1 de liaison au facteur de croissance des fibroblastes (FGFBP1) dans un échantillon du sujet.</description><language>eng ; fre</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240125&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024017985A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240125&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024017985A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SILLMAN, Johanna Carolina</creatorcontrib><creatorcontrib>MANG, Anika</creatorcontrib><creatorcontrib>HUND, Martin</creatorcontrib><creatorcontrib>MARTIN, Klammer</creatorcontrib><creatorcontrib>ALLEGRANZA, Deirdre Mary</creatorcontrib><creatorcontrib>DI DOMENICO, Annunziata</creatorcontrib><title>FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME</title><description>The present invention relates to a method for assessing whether a subject has Polycystic Ovarian Syndrome (PCOS) or is at risk of developing PCOS, to a method of selecting a patient for therapy of PCOS, to a method for monitoring PCOS progression or for monitoring response to treatment and to a computer- implemented method for assessing a subject with suspected PCOS, by determining the amount or concentration of Fibroblast Growth Factor-Binding Protein 1 (FGFBP1) in a sample of the subject. La présente invention concerne un procédé pour évaluer si un sujet a un syndrome des ovaires polykystiques (SOPK) ou est à risque de développer un SOPK, un procédé de sélection d'un patient pour une thérapie de SOPK, un procédé de surveillance de la progression du SOPK ou de surveillance de la réponse à un traitement et un procédé mis en oeuvre par ordinateur pour évaluer un sujet suspecté d'être atteint de SOPK, par détermination de la quantité ou de la concentration de la protéine 1 de liaison au facteur de croissance des fibroblastes (FGFBP1) dans un échantillon du sujet.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7sKwjAUgOEuDqK-wwGXdhAaL6hj7g22OSUJlk6lSJxEC3Xx7e3gAzj9y_fPk48yzCErqQ-gHTahAEV5QAfMWGGshtphkMYCgVRpxWqSAfWQshJRZJPCirqLdKCmJxQShKHaojceUEGNZctbHwwHvFJnqAXfWuGwkstkdu8fY1z9ukjWSgZebOLw6uI49Lf4jO-uwW2-3efkeD4dKNn9p75HIzqV</recordid><startdate>20240125</startdate><enddate>20240125</enddate><creator>SILLMAN, Johanna Carolina</creator><creator>MANG, Anika</creator><creator>HUND, Martin</creator><creator>MARTIN, Klammer</creator><creator>ALLEGRANZA, Deirdre Mary</creator><creator>DI DOMENICO, Annunziata</creator><scope>EVB</scope></search><sort><creationdate>20240125</creationdate><title>FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME</title><author>SILLMAN, Johanna Carolina ; MANG, Anika ; HUND, Martin ; MARTIN, Klammer ; ALLEGRANZA, Deirdre Mary ; DI DOMENICO, Annunziata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024017985A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SILLMAN, Johanna Carolina</creatorcontrib><creatorcontrib>MANG, Anika</creatorcontrib><creatorcontrib>HUND, Martin</creatorcontrib><creatorcontrib>MARTIN, Klammer</creatorcontrib><creatorcontrib>ALLEGRANZA, Deirdre Mary</creatorcontrib><creatorcontrib>DI DOMENICO, Annunziata</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SILLMAN, Johanna Carolina</au><au>MANG, Anika</au><au>HUND, Martin</au><au>MARTIN, Klammer</au><au>ALLEGRANZA, Deirdre Mary</au><au>DI DOMENICO, Annunziata</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME</title><date>2024-01-25</date><risdate>2024</risdate><abstract>The present invention relates to a method for assessing whether a subject has Polycystic Ovarian Syndrome (PCOS) or is at risk of developing PCOS, to a method of selecting a patient for therapy of PCOS, to a method for monitoring PCOS progression or for monitoring response to treatment and to a computer- implemented method for assessing a subject with suspected PCOS, by determining the amount or concentration of Fibroblast Growth Factor-Binding Protein 1 (FGFBP1) in a sample of the subject. La présente invention concerne un procédé pour évaluer si un sujet a un syndrome des ovaires polykystiques (SOPK) ou est à risque de développer un SOPK, un procédé de sélection d'un patient pour une thérapie de SOPK, un procédé de surveillance de la progression du SOPK ou de surveillance de la réponse à un traitement et un procédé mis en oeuvre par ordinateur pour évaluer un sujet suspecté d'être atteint de SOPK, par détermination de la quantité ou de la concentration de la protéine 1 de liaison au facteur de croissance des fibroblastes (FGFBP1) dans un échantillon du sujet.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2024017985A1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A25%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SILLMAN,%20Johanna%20Carolina&rft.date=2024-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024017985A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true